{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:12:32Z","timestamp":1787163152542,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T00:00:00Z","timestamp":1673136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T00:00:00Z","timestamp":1673136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00432-022-04569-y","type":"journal-article","created":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T21:02:35Z","timestamp":1673125355000},"page":"5989-5998","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Characteristics, treatment, and outcome of patients with bowel perforation after immune checkpoint inhibitor exposure"],"prefix":"10.1007","volume":"149","author":[{"given":"Antonio","family":"Pizuorno Machado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malek","family":"Shatila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Altan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella C.","family":"Glitza Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao Chi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anusha","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,8]]},"reference":[{"issue":"3","key":"4569_CR1","doi-asserted-by":"publisher","first-page":"e14093","DOI":"10.7759\/cureus.14093","volume":"13","author":"R Adhikari","year":"2021","unstructured":"Adhikari R, Ghose M, Tekin A, Singh S, Singh R (2021) Intestinal perforation: a rare complication of treatment with bevacizumab. Cureus 13(3):e14093. https:\/\/doi.org\/10.7759\/cureus.14093","journal-title":"Cureus"},{"issue":"3","key":"4569_CR2","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/annonc\/mdm508","volume":"19","author":"BD Badgwell","year":"2008","unstructured":"Badgwell BD, Camp ER, Feig B, Wolff RA, Eng C, Ellis LM, Cormier JN (2008) Management of bevacizumab-associated bowel perforation: a case series and review of the literature. Ann Oncol 19(3):577\u2013582. https:\/\/doi.org\/10.1093\/annonc\/mdm508","journal-title":"Ann Oncol"},{"issue":"1","key":"4569_CR3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4103\/aam.aam_11_18","volume":"18","author":"OS Balogun","year":"2019","unstructured":"Balogun OS, Osinowo A, Afolayan M, Olajide T, Lawal A, Adesanya A (2019) Acute perforated appendicitis in adults: management and complications in Lagos Nigeria. Ann Afr Med 18(1):36\u201341. https:\/\/doi.org\/10.4103\/aam.aam_11_18","journal-title":"Ann Afr Med"},{"issue":"6","key":"4569_CR4","doi-asserted-by":"publisher","first-page":"414","DOI":"10.5114\/wo.2014.46362","volume":"18","author":"Z Banaszkiewicz","year":"2014","unstructured":"Banaszkiewicz Z, Woda \u0141, Tojek K, Jarmocik P, Jawie\u0144 A (2014) Colorectal cancer with intestinal perforation\u2014a retrospective analysis of treatment outcomes. Contemp Oncol (poznan, Poland) 18(6):414\u2013418. https:\/\/doi.org\/10.5114\/wo.2014.46362","journal-title":"Contemp Oncol (poznan, Poland)"},{"key":"4569_CR5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s11894-002-0079-y","volume":"4","author":"MF Bavaro","year":"2002","unstructured":"Bavaro MF (2002) Neutropenic enterocolitis. Curr Gastroenterol Rep 4:297\u2013301","journal-title":"Curr Gastroenterol Rep"},{"key":"4569_CR6","unstructured":"Beck T N (2020) Colonic Perforation after Dual Ipilimumab and Nivolumab Treatment. Case Reviews in Surgery. 2:9"},{"key":"4569_CR7","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s12885-019-5577-5","volume":"19","author":"TN Beck","year":"2019","unstructured":"Beck TN, Kudinov AE, Dulaimi E et al (2019) Case report: reinitiating pembrolizumab treatment after small bowel perforation. BMC Cancer 19:379","journal-title":"BMC Cancer"},{"key":"4569_CR8","doi-asserted-by":"publisher","first-page":"rju010","DOI":"10.1093\/jscr\/rju010","volume":"3","author":"L Burdine","year":"2014","unstructured":"Burdine L, Lai K (2014) Laryea J A (2014) Ipilimumab-induced colonic perforation. J Surg Case Reports 3:rju010. https:\/\/doi.org\/10.1093\/jscr\/rju010","journal-title":"J Surg Case Reports"},{"key":"4569_CR9","doi-asserted-by":"publisher","first-page":"3406437","DOI":"10.1155\/2018\/3406437","volume":"2018","author":"R Celli","year":"2018","unstructured":"Celli R, Kluger HM, Zhang X (2018) Anti-PD-1 therapy-associated perforating colitis. Case Rep Gastrointest Med 2018:3406437. https:\/\/doi.org\/10.1155\/2018\/3406437","journal-title":"Case Rep Gastrointest Med"},{"issue":"5","key":"4569_CR10","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1148\/rg.2017160162","volume":"37","author":"ST Chang","year":"2017","unstructured":"Chang ST, Menias CO, Lubner MG, Mellnick VM, Hara AK, Desser TS (2017) Molecular and clinical approach to intra-abdominal adverse effects of targeted cancer therapies. Radiographics 37(5):1461\u20131482. https:\/\/doi.org\/10.1148\/rg.2017160162","journal-title":"Radiographics"},{"issue":"6","key":"4569_CR11","doi-asserted-by":"publisher","first-page":"e66721","DOI":"10.1371\/journal.pone.0066721","volume":"8","author":"XL Chen","year":"2013","unstructured":"Chen XL, Lei YH, Liu CF, Yang QF, Zuo PY, Liu CY, Chen CZ, Liu YW (2013) Angiogenesis inhibitor bevacizumab increases the risk of ischemic heart disease associated with chemotherapy: a meta-analysis. PLoS ONE 8(6):e66721. https:\/\/doi.org\/10.1371\/journal.pone.0066721","journal-title":"PLoS ONE"},{"key":"4569_CR12","unstructured":"Cho S J (2019) Intraepithelial lymphocytes in the gastrointestinal tract: to celiac disease and beyond. Current Issues in Anatomic Pathology 1:19"},{"issue":"1","key":"4569_CR13","first-page":"78","volume":"5","author":"DC Chow","year":"1997","unstructured":"Chow DC, Babaian M, Taubin HL (1997) Jejunoileal diverticula. Gastroenterologist 5(1):78\u201384","journal-title":"Gastroenterologist"},{"key":"4569_CR14","doi-asserted-by":"publisher","first-page":"9069354","DOI":"10.1155\/2019\/9069354","volume":"2019","author":"L Delasos","year":"2019","unstructured":"Delasos L, Desai A, Lopetegui Lia N, Kethireddy N, Ray C (2019) A case of immunotherapy-induced colitis complicated by perforation and treated with infliximab postoperatively. Case Rep Oncol Med 2019:9069354. https:\/\/doi.org\/10.1155\/2019\/9069354","journal-title":"Case Rep Oncol Med"},{"key":"4569_CR15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.2478\/pjs-2014-0017","volume":"86","author":"P Dilling","year":"2014","unstructured":"Dilling P, Walczak J, Pikiel P et al (2014) Multiple colon perforation as a fatal complication during treatment of metastatic melanoma with ipilimumab\u2014case report. Pol Przegl Chir 86:94\u201396","journal-title":"Pol Przegl Chir"},{"issue":"suppl_4","key":"4569_CR16","doi-asserted-by":"publisher","first-page":"iv119","DOI":"10.1093\/annonc\/mdx225","volume":"28","author":"J Haanen","year":"2017","unstructured":"Haanen J, Carbonnel F, Robert C, Kerr KM, Peters S, Larkin J, Jordan K (2017) Management of toxicities from immunotherapy: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 28(suppl_4):iv119\u2013iv142. https:\/\/doi.org\/10.1093\/annonc\/mdx225","journal-title":"Ann Oncol"},{"issue":"6","key":"4569_CR17","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S1470-2045(09)70112-3","volume":"10","author":"S Hapani","year":"2009","unstructured":"Hapani S, Chu D, Wu S (2009) Risk of gastrointestinal perforation in patients with cancer treated with bevacizumab: a meta-analysis. Lancet Oncol 10(6):559\u2013568. https:\/\/doi.org\/10.1016\/S1470-2045(09)70112-3","journal-title":"Lancet Oncol"},{"issue":"2","key":"4569_CR18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3892\/mco.2019.1871","volume":"11","author":"HK Kim","year":"2019","unstructured":"Kim HK, Baek SW, Jeong Y, Yang Y, Kwon J, Han HS, An JY, Woo CG, Lee OJ, Lee TG, Lee KH (2019) Pseudoprogression presenting as intestinal perforation in non-small cell lung cancer treated with anti-PD-1: a case report. Mol Clin Oncol 11(2):132\u2013134. https:\/\/doi.org\/10.3892\/mco.2019.1871","journal-title":"Mol Clin Oncol"},{"issue":"6","key":"4569_CR19","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.3390\/molecules24061190","volume":"24","author":"HT Lee","year":"2019","unstructured":"Lee HT, Lee SH, Heo YS (2019) Molecular interactions of antibody drugs targeting PD-1, PD-L1, and CTLA-4 in immuno-oncology. Mol (basel, Switzerland) 24(6):1190. https:\/\/doi.org\/10.3390\/molecules24061190","journal-title":"Mol (basel, Switzerland)"},{"issue":"3","key":"4569_CR20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s11523-017-0495-4","volume":"12","author":"C Prieux-Klotz","year":"2017","unstructured":"Prieux-Klotz C, Dior M, Damotte D, Dreanic J, Brieau B, Brezault C, Abitbol V, Chaussade S, Coriat R (2017) Immune checkpoint inhibitor-induced colitis: diagnosis and management. Target Oncol 12(3):301\u2013308. https:\/\/doi.org\/10.1007\/s11523-017-0495-4","journal-title":"Target Oncol"},{"key":"4569_CR21","volume-title":"common terminology criteria for adverse events (CTCAE) Version 5.0","author":"Services UDoHaH","year":"2017","unstructured":"Services UDoHaH (2017) common terminology criteria for adverse events (CTCAE) Version 5.0. Institute NIoHNC, Cary"},{"issue":"4","key":"4569_CR22","doi-asserted-by":"publisher","first-page":"e1182","DOI":"10.7759\/cureus.1182","volume":"9","author":"R Shah","year":"2017","unstructured":"Shah R, Witt D, Asif T, Mir FF (2017) Ipilimumab as a cause of severe pan-colitis and colonic perforation. Cureus 9(4):e1182. https:\/\/doi.org\/10.7759\/cureus.1182","journal-title":"Cureus"},{"issue":"3","key":"4569_CR23","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1159\/000510131","volume":"14","author":"DH Shaikh","year":"2020","unstructured":"Shaikh DH, Baiomi A, Mehershahi S, Abbas H, Gongati S, Nayudu SK (2020) Paclitaxel-induced bowel perforation: a rare cause of acute abdomen. Case Rep Gastroenterol 14(3):687\u2013694. https:\/\/doi.org\/10.1159\/000510131","journal-title":"Case Rep Gastroenterol"},{"issue":"6","key":"4569_CR24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3393\/ac.2016.32.6.221","volume":"32","author":"R Shin","year":"2016","unstructured":"Shin R, Lee SM, Sohn B, Lee DW, Song I, Chai YJ, Lee HW, Ahn HS, Jung IM, Chung JK, Heo SC (2016) Predictors of morbidity and mortality after surgery for intestinal perforation. Ann Coloproctol 32(6):221\u2013227. https:\/\/doi.org\/10.3393\/ac.2016.32.6.221","journal-title":"Ann Coloproctol"},{"key":"4569_CR25","doi-asserted-by":"publisher","first-page":"175628481988419","DOI":"10.1177\/1756284819884196","volume":"12","author":"UN Shivaji","year":"2019","unstructured":"Shivaji UN, Jeffery L, Gui X, Smith S, Ahmad OF, Akbar A, Ghosh S, Iacucci M (2019) Immune checkpoint inhibitor-associated gastrointestinal and hepatic adverse events and their management. Ther Adv Gastroenterol 12:1756284819884196. https:\/\/doi.org\/10.1177\/1756284819884196","journal-title":"Ther Adv Gastroenterol"},{"issue":"1","key":"4569_CR26","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/01.cji.0000211334.06762.89","volume":"30","author":"FO Smith","year":"2007","unstructured":"Smith FO, Goff SL, Klapper JA, Levy C, Allen T, Mavroukakis SA, Rosenberg SA (2007) Risk of bowel perforation in patients receiving interleukin-2 after therapy with anti-CTLA 4 monoclonal antibody. J Immunother (hagerstown Md: 1997) 30(1):130. https:\/\/doi.org\/10.1097\/01.cji.0000211334.06762.89","journal-title":"J Immunother (hagerstown Md: 1997)"},{"issue":"3","key":"4569_CR27","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1016\/j.clcc.2020.03.002","volume":"19","author":"T Tang","year":"2020","unstructured":"Tang T, Abu-Sbeih H, Ma W, Lu Y, Luo W, Foo WC, Richards DM, Halperin DM, Ge PS, Wang Y (2020) Gastrointestinal injury related to antiangiogenesis cancer therapy. Clin Colorectal Cancer 19(3):e117\u2013e123. https:\/\/doi.org\/10.1016\/j.clcc.2020.03.002","journal-title":"Clin Colorectal Cancer"},{"key":"4569_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/978-3-030-02505-2_7","volume":"995","author":"Y Tian","year":"2018","unstructured":"Tian Y, Abu-Sbeih H, Wang Y (2018) Immune checkpoint inhibitors-induced colitis. Adv Exp Med Biol 995:151\u2013157. https:\/\/doi.org\/10.1007\/978-3-030-02505-2_7","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"4569_CR29","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1159\/000514182","volume":"10","author":"L Valerio","year":"2021","unstructured":"Valerio L, Giani C, Agate L, Molinaro E, Viola D, Bottici V, Matrone A, Puleo L, Lorusso L, Cappagli V, Ribechini A, Elisei R (2021) Prevalence and risk factors of developing fistula or organ perforation in patients treated with lenvatinib for radioiodine-refractory thyroid cancer. Eur Thyroid J 10(5):399\u2013407. https:\/\/doi.org\/10.1159\/000514182","journal-title":"Eur Thyroid J"},{"key":"4569_CR30","doi-asserted-by":"publisher","first-page":"goab054","DOI":"10.1093\/gastro\/goab054","volume":"10","author":"J Wu","year":"2021","unstructured":"Wu J, Shu P, He H, Li H, Tang Z, Sun Y, Liu F (2021) Predictors of mortality in patients with acute small-bowel perforation transferred to ICU after emergency surgery: a single-centre retrospective cohort study. Gastroenterol Report 10:goab054. https:\/\/doi.org\/10.1093\/gastro\/goab054","journal-title":"Gastroenterol Report"},{"issue":"1","key":"4569_CR31","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s40792-017-0370-7","volume":"3","author":"K Yasuda","year":"2017","unstructured":"Yasuda K, Tanaka T, Ishihara S, Otani K, Nishikawa T, Kiyomatsu T, Kawai K, Hata K, Nozawa H, Masui Y, Shintani Y, Watanabe T (2017) Intestinal perforation after nivolumab immunotherapy for a malignant melanoma: a case report. Surgical Case Reports 3(1):94. https:\/\/doi.org\/10.1186\/s40792-017-0370-7","journal-title":"Surgical Case Reports"},{"key":"4569_CR32","volume-title":"EC: oncologic emergencies","author":"SC Yeun","year":"2022","unstructured":"Yeun SC (2022) EC: oncologic emergencies. BC Decker Inc, Hamilton"},{"key":"4569_CR33","doi-asserted-by":"publisher","first-page":"S1856","DOI":"10.14309\/01.ajg.0000780956.51825.dd","volume":"116","author":"WF Zhou","year":"2021","unstructured":"Zhou WF, Joseph SC, Berry R (2021) S1856 a life-threatening cause of diarrhea: a case of immune checkpoint inhibitor colitis. Am J Gastroenterol 116:S1856","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"4569_CR34","doi-asserted-by":"publisher","first-page":"700","DOI":"10.6004\/jnccn.2020.7647","volume":"19","author":"F Zou","year":"2020","unstructured":"Zou F, Abu-Sbeih H, Ma W, Peng Y, Qiao W, Wang J, Shah AY, Glitza Oliva IC, Piha-Paul SA, Thompson JA, Zhang HC, Thomas AS, Wang Y (2020) Association of chronic immune-mediated diarrhea and colitis with favorable cancer response. J Natl Compr Cancer Netw 19(6):700\u2013708. https:\/\/doi.org\/10.6004\/jnccn.2020.7647","journal-title":"J Natl Compr Cancer Netw"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-04569-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-022-04569-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-04569-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T08:12:23Z","timestamp":1689754343000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-022-04569-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,8]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["4569"],"URL":"https:\/\/doi.org\/10.1007\/s00432-022-04569-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2137043\/v1","asserted-by":"object"}]},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,8]]},"assertion":[{"value":"6 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have not received any financial consideration from any person or organization to support the preparation, analysis, results or discussion of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}